These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 9346228

  • 21. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R.
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [Abstract] [Full Text] [Related]

  • 25. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
    Fountzilas G, Athanassiadis A, Samantas E, Skarlos D, Kalogera-Fountzila A, Nikolaou A, Bacoyiannis H, Stathopoulos G, Kosmidis P, Daniilidis J.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340
    [Abstract] [Full Text] [Related]

  • 26. Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up.
    Sorbe B, Andersson H, Boman K, Rosenberg P, Kalling M.
    Int J Gynecol Cancer; 2008 Feb; 18(4):803-8. PubMed ID: 17944917
    [Abstract] [Full Text] [Related]

  • 27. Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials.
    Muggia FM, Vafai D, Natale R, Israel V, Zaretsky S, McRae A, Rogers M, Jeffers S.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):63-6. PubMed ID: 7644931
    [Abstract] [Full Text] [Related]

  • 28. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 29. Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma.
    Vandenput I, Vergote I, Leunen K, Berteloot P, Neven P, Amant F.
    Int J Gynecol Cancer; 2009 Aug; 19(6):1147-51. PubMed ID: 19820384
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

  • 32. Combination therapy with paclitaxel, carboplatin and megestrol acetate for the management of advanced stage or recurrent carcinoma of the endometrium: a phase II study.
    Bevis KS, Kilgore LC, Alvarez RD, Straughn JM, Leath CA.
    J Reprod Med; 2014 Dec; 59(3-4):113-20. PubMed ID: 24724218
    [Abstract] [Full Text] [Related]

  • 33. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M, Petruzelka L, Pazdro A, Kralova D, Smejkal M, Pazdrova G, Honova H.
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma.
    Arimoto T, Nakagawa S, Yasugi T, Yoshikawa H, Kawana K, Yano T, Taketani Y.
    Gynecol Oncol; 2007 Jan; 104(1):32-5. PubMed ID: 16996113
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [Abstract] [Full Text] [Related]

  • 39. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [Abstract] [Full Text] [Related]

  • 40. Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
    Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanasiadis A, Skarlos D.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.